Logo-jcvtr

J Cardiovasc Thorac Res. 2023;15(2): 68-72. doi: 10.34172/jcvtr.2023.31830
PMID: 37654821        PMCID: PMC10466470

Review Article

Human cardiac organoids: A recent revolution in disease modeling and regenerative medicine

Neda Roshanravan 1 * ORCID, Samad Ghaffari 1 ORCID, Sepideh Bastani 2, Sara Pahlavan 3, Samira Asghari 4, Mohammad Amin Doustvandi 5, Sepideh Jalilzadeh- Razin 6, Mohammadreza Dastouri 7 * ORCID

Cited by CrossRef: 0

1- Chandra Sekar N, Khoshmanesh K, Baratchi S. Bioengineered models of cardiovascular diseases. Atherosclerosis. 2024;393:117565 [Crossref]
2- Kar R, Mukhopadhyay D, Angom R. Progress in Disease Modeling for Myocardial Infarction and Coronary Artery Disease: Bridging In Vivo and In Vitro Approaches. Hearts. 2024;5(4):429 [Crossref]
3- Paredes-Espinosa M, Paluh J. Synthetic embryology of the human heart. Front Cell Dev Biol. 2025;12 [Crossref]
4- Derobertmasure A, Toh L, Wotring V, Williams P, Morbidelli L, Stingl J, Vinken M, Ramadan R, Chhun S, Boutouyrie P. Pharmacological countermeasures for long-duration space missions: addressing cardiovascular challenges and advancing space-adapted healthcare. European Journal of Pharmaceutical Sciences. 2025;209:107063 [Crossref]
5- Gokhan I, Blum T, Campbell S. Engineered heart tissue: Design considerations and the state of the art. 2024;5(2) [Crossref]
6- Liu X, Zhou Z, Zhang Y, Zhong H, Cai X, Guan R. Recent progress on the organoids: Techniques, advantages and applications. Biomedicine & Pharmacotherapy. 2025;185:117942 [Crossref]
7- Lee S, Lee H. Advances in cardiac organoid technology: current trends and standardized quality assessment for toxicity testing in preclinical models. Organoid. 2024;4:e6 [Crossref]
8- Vo Q, Nakamura K, Saito Y, Akagi S, Miyoshi T, Yuasa S. Induced Pluripotent Stem Cells in Cardiomyopathy: Advancing Disease Modeling, Therapeutic Development, and Regenerative Therapy. IJMS. 2025;26(11):4984 [Crossref]